TP53BP1 and in situ carcinoma: To compare the numbers of lymphocytic γ-H2AX and 53BP1 foci in freshly isolated PBMCs from patients with CIS/early RRMS and healthy controls, we used a previously established immunocytochemical staining technique combined with an automated reading system [14,15].